不利的童年经历和抗抑郁药治疗:一个系统的审查
Dixie Meyer1, Ali Abid2, Awais Paracha3
1Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA.
Missouri medicine
|October 24, 2025
概括
儿童不良经历 (ACE) 与抑郁症有关,并影响抗抑郁药 (ADM) 的有效性. 了解ACE对于个性化抑郁症治疗和监测幸存者的自杀风险至关重要.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 童年不良经历 (ACE) 与抑郁症风险增加有关.
- ACE 对抗抑郁药 (ADM) 治疗结果的影响需要进一步研究.
- 有限的累积研究存在于特定的ACE及其与ADM结果的结合.
研究的目的:
- 审查和综合现有关于ACE和ADM治疗之间的关系的研究.
- 检查ACE如何影响抗抑郁药物的疗效和结果.
- 在ACEs-ADM关系中识别模式和潜在的调节者.
主要方法:
- 在PsychInfo和PubMed/MEDLINE数据库 (2010-2025) 的系统文献搜索.
- 包括26个同行评审的出版物,同时检查了ACE和ADM.
- 分析与ACE,ADM使用,疗效和患者结局相关的发现.
主要成果:
- ACE与较高的ADM使用,改变影响ADM疗效的DNA甲基化和ADM治疗期间自杀风险增加相关.
- 选择性血清素再吸收抑制剂 (SSRI) 和血清素-上腺素再吸收抑制剂 (SNRIs) 对 ACE 幸存者来说是有前途的.
- 多个ACE和虐待儿童可能会降低ADM的有效性,可能会因遗传因素和暴露年龄而受到缓解.
结论:
- 经过ACE史是影响抑郁症和对ADMs的反应的一个重要因素.
- 医疗保健提供者应查ACE并考虑量身定制的治疗策略,包括仔细监测持续症状和自杀风险.
- 需要进一步研究更大的样本大小和受控比较,以澄清复杂的ACEs-ADM相互作用.
相关概念视频
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
Attention-Deficit/Hyperactivity Disorder
743
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
743
Electroconvulsive Therapy
864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437


